Continuous subcutaneous levodopa–carbidopa infusion for Parkinson's disease

Harmen R. Moes; Erik Buskens; Teus van Laar

doi:10.1016/S1474-4422(24)00272-2

Continuous subcutaneous levodopa–carbidopa infusion for Parkinson's disease

Harmen R. Moes^*, Erik Buskens, Teus van Laar

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	856-857
Number of pages	2
Journal	The Lancet Neurology
Volume	23
Issue number	9
DOIs	https://doi.org/10.1016/S1474-4422(24)00272-2
Publication status	Published - Sept-2024

Access to Document

10.1016/S1474-4422(24)00272-2

Continuous subcutaneous levodopa–carbidopa infusion for Parkinson's diseaseFinal publisher's version, 62.8 KBLicence: Taverne

Handle.net

Persistent link

Cite this

@article{d1aeb752bb314e65bd0862a77bc48628,

title = "Continuous subcutaneous levodopa–carbidopa infusion for Parkinson's disease",

author = "Moes, {Harmen R.} and Erik Buskens and {van Laar}, Teus",

year = "2024",

month = sep,

doi = "10.1016/S1474-4422(24)00272-2",

language = "English",

volume = "23",

pages = "856--857",

journal = "The Lancet Neurology",

issn = "1474-4422",

publisher = "ELSEVIER SCIENCE INC",

number = "9",

}

TY - JOUR

T1 - Continuous subcutaneous levodopa–carbidopa infusion for Parkinson's disease

AU - Moes, Harmen R.

AU - Buskens, Erik

AU - van Laar, Teus

PY - 2024/9

Y1 - 2024/9

UR - http://www.scopus.com/inward/record.url?scp=85201064814&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(24)00272-2

DO - 10.1016/S1474-4422(24)00272-2

M3 - Letter

C2 - 39152017

AN - SCOPUS:85201064814

SN - 1474-4422

VL - 23

SP - 856

EP - 857

JO - The Lancet Neurology

JF - The Lancet Neurology

IS - 9

ER -

Continuous subcutaneous levodopa–carbidopa infusion for Parkinson's disease

Access to Document

Handle.net

Other files and links

Cite this